CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -5.34%218.25M | 12.24%1.17B | 15.07%798.48M | 15.47%495.29M | 30.63%230.55M | 17.58%1.04B | 9.79%693.88M | 11.94%428.95M | 12.35%176.49M | -24.93%885.21M |
Refunds of taxes and levies | 4,803.28%8.96M | 81.25%4.66M | -26.36%2.61M | -85.74%457.6K | -93.09%182.81K | -39.13%2.57M | 179.31%3.54M | 284.88%3.21M | --2.65M | 111.54%4.22M |
Net deposit increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in borrowings from central bank | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in placements from other financial institutions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash received from interests, fees and commissions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in repurchase business capital | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Premiums received from original insurance contracts | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net cash received from reinsurance business | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in deposits from policyholders | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net increase in funds disbursed | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net cash received from trading securities | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash received relating to other operating activities | 80.55%12.62M | -52.60%33.87M | -57.67%32.04M | -67.09%17.15M | -80.83%6.99M | -27.14%71.44M | 24.25%75.7M | 2.74%52.12M | 54.37%36.45M | 139.16%98.06M |
Cash inflows from operating activities | 0.89%239.83M | 8.24%1.21B | 7.76%833.13M | 5.91%512.9M | 10.27%237.72M | 12.90%1.11B | 11.37%773.12M | 11.39%484.28M | 19.31%215.58M | -19.20%987.49M |
Goods services cash paid | 1.22%196.03M | -6.65%734.81M | -8.02%556.6M | -19.46%339.08M | -31.83%193.67M | 0.92%787.14M | -3.17%605.16M | 12.86%421M | 29.88%284.1M | 44.43%779.99M |
Staff behalf paid | -24.51%53.78M | 5.52%241.65M | 11.75%185.87M | 16.17%124.61M | 29.69%71.25M | 8.07%229M | 2.53%166.33M | -0.55%107.27M | -9.94%54.94M | -24.02%211.9M |
All taxes paid | -58.78%8.53M | 15.78%49.26M | 45.18%38.81M | 165.67%32.74M | 871.90%20.69M | 46.57%42.54M | 24.60%26.73M | 26.96%12.32M | -75.97%2.13M | -57.70%29.03M |
Net loan and advance increase | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net deposit in central bank and institutions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net lend capital | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash paid for fees and commissions | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash paid for indemnity of original insurance contract | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Policy dividend cash paid | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash paid relating to other operating activities | 21.68%29.98M | -19.77%90.86M | -39.71%74.21M | -42.13%48.33M | -51.51%24.64M | 16.16%113.26M | 103.15%123.08M | 88.73%83.51M | 81.81%50.82M | -54.79%97.51M |
Cash outflows from operating activities | -7.07%288.32M | -4.72%1.12B | -7.14%855.5M | -12.71%544.76M | -20.85%310.24M | 4.79%1.17B | 5.99%921.3M | 16.69%624.09M | 23.83%391.99M | 1.38%1.12B |
Net cash flows from operating activities | 33.13%-48.5M | 257.92%90.16M | 84.90%-22.37M | 77.21%-31.86M | 58.89%-72.52M | 56.40%-57.09M | 15.35%-148.18M | -39.71%-139.82M | -29.86%-176.41M | -210.14%-130.93M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 557.25%331.91M | 132.16%412.04M | 215.11%241.03M | 157.13%82.71M | 741.66%50.5M | -79.90%177.48M | -90.54%76.49M | -95.67%32.17M | -97.79%6M | -57.46%883.05M |
Cash received from returns on investments | 301.12%375.55K | 248.86%871.92K | -5.02%-925.45K | -10.90%-697.92K | -21.95%-186.73K | -96.16%249.94K | -119.23%-881.24K | -113.48%-629.31K | -110.39%-153.11K | -62.99%6.51M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -64.01%22.23K | -94.33%133.37K | -92.79%482.45K | -92.63%269.79K | 24.81%61.76K | 599.09%2.35M | 3,836.99%6.69M | 97.88%3.66M | -96.33%49.48K | -87.38%336.18K |
Net cash received from disposal of subsidiaries and other business units | ---- | --2 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash received relating to other investing activities | ---- | --0 | ---- | ---- | --0 | --0 | ---- | --0 | ---- | ---- |
Cash inflows from investing activities | 559.67%332.31M | 129.37%413.04M | 192.33%240.59M | 133.77%82.28M | 754.33%50.38M | -79.76%180.08M | -89.88%82.3M | -95.30%35.2M | -97.85%5.9M | -57.54%889.9M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -17.57%3.9M | -79.75%21.76M | -82.39%19.18M | -83.31%11.89M | -74.22%4.73M | -70.83%107.48M | -66.84%108.89M | 195.90%71.2M | -14.01%18.33M | 189.75%368.49M |
Cash paid to acquire investments | 617.12%464.68M | 135.63%451.31M | 42.24%289.21M | 69.34%182.02M | 29.79%64.8M | -70.81%191.54M | -68.91%203.33M | -81.61%107.49M | -89.49%49.93M | -61.30%656.15M |
Net cash paid to acquire subsidiaries and other business units | ---- | --0 | ---- | ---- | --0 | -81.10%18.66M | ---- | ---- | ---- | --98.7M |
Impawned loan net increase | ---- | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash paid relating to other investing activities | ---- | --10.22M | 584.76%10.22M | --10.22M | --0 | --0 | ---2.11M | --0 | ---- | ---- |
Cash outflows from investing activities | 573.96%468.57M | 52.13%483.29M | 2.74%318.61M | 14.24%204.12M | 1.85%69.52M | -71.72%317.68M | -71.48%310.11M | -70.78%178.68M | -86.25%68.26M | -38.37%1.12B |
Net cash flows from investing activities | -611.56%-136.26M | 48.94%-70.25M | 65.75%-78.02M | 15.09%-121.84M | 69.29%-19.15M | 41.06%-137.6M | 16.77%-227.81M | -204.18%-143.48M | 71.85%-62.36M | -185.48%-233.45M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | -50.00%400K | -98.37%1M | -97.33%1M | -97.47%400K | --800K | --61.43M | 2,242.96%37.49M | --15.79M | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | -50.00%400K | ---- | ---- | ---- | --800K | ---- | ---- | ---- | ---- |
Cash from borrowing | 190.07%93.43M | -31.64%247.71M | -38.01%209.03M | -82.29%42.03M | -85.33%32.21M | 1,047.50%362.38M | 1,869.51%337.18M | 2,272.90%237.29M | --219.49M | -22.65%31.58M |
Cash received relating to other financing activities | ---- | --580K | ---- | --0 | --0 | --0 | ---- | --0 | ---- | ---- |
Cash inflows from financing activities | 186.51%93.43M | -31.52%248.69M | -47.31%210.03M | -84.34%43.03M | -86.14%32.61M | 1,050.03%363.18M | 2,228.32%398.61M | 2,268.77%274.78M | --235.28M | -22.65%31.58M |
Borrowing repayment | 1.06%45.93M | 44.80%251.09M | 628.89%230.45M | 230.84%66.26M | 413.51%45.45M | 389.14%173.4M | -29.96%31.62M | 100.26%20.03M | --8.85M | 1,325.83%35.45M |
Dividend interest payment | -17.17%2.03M | -29.76%13.82M | -29.94%11.36M | -30.01%9.39M | 88.93%2.45M | 172.13%19.67M | 154.99%16.21M | 140.81%13.42M | 196.07%1.3M | -55.26%7.23M |
-Including:Cash payments for dividends or profit to minority shareholders | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash payments relating to other financing activities | -86.57%405.81K | -53.87%13.53M | -46.94%6.88M | -40.13%5.72M | -38.75%3.02M | -4.53%29.33M | -40.74%12.97M | -33.50%9.56M | -30.86%4.93M | 8.47%30.73M |
Cash outflows from financing activities | -5.02%48.36M | 25.19%278.44M | 309.04%248.69M | 89.21%81.37M | 237.62%50.92M | 202.99%222.41M | -17.15%60.8M | 43.60%43.01M | 99.09%15.08M | 56.28%73.4M |
Net cash flows from financing activities | 346.15%45.07M | -121.13%-29.75M | -111.44%-38.66M | -116.54%-38.34M | -108.31%-18.31M | 436.58%140.77M | 700.41%337.81M | 1,363.13%231.77M | 3,006.85%220.2M | -581.00%-41.82M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -105.37%-3.84K | -91.95%186.76K | -104.91%-107.47K | -93.15%114.3K | 150.71%71.57K | 526.07%2.32M | 516.27%2.19M | 770.63%1.67M | -460.39%-141.13K | 177.39%370.38K |
Net increase in cash and cash equivalents | -27.10%-139.7M | 81.28%-9.66M | -286.62%-139.15M | -284.90%-191.93M | -487.30%-109.91M | 87.29%-51.6M | 92.87%-35.99M | -355.81%-49.86M | 94.87%-18.71M | -205.32%-405.83M |
Add:Begin period cash and cash equivalents | -2.09%456.8M | -9.96%466.45M | -10.51%466.45M | -9.96%466.45M | -9.94%466.56M | -43.93%518.05M | -43.96%521.21M | -43.93%518.05M | -43.93%518.05M | 71.56%923.88M |
End period cash equivalent | -11.09%317.1M | -2.07%456.8M | -32.55%327.3M | -41.36%274.53M | -28.57%356.65M | -9.96%466.45M | 14.07%485.22M | -50.37%468.19M | -10.66%499.34M | -43.93%518.05M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.